RMTG's Successful ISSCA Buenos Aires Argentina Event Draws Hundreds of Physicians, Announces Seven Additional Training Events in 2025

About this update from Regenerative Medical Technology Group Inc.

[{"type":"text","content":"\r\n\r\n \r\n \r\n RMTG's Successful ISSCA Buenos Aires Argentina Event Draws Hundreds of Physicians, Announces Seven Additional Training Events in 2025\r\n \r\n \r\n\r\n\r\nRMTG's Successful ISSCA Buenos Aires Argentina Event Draws Hundreds of Physicians, Announces Seven Additional Training Events in 2025\r\n\r\n\r\n\r\n\r\n\r\nArgentina Success Validates Global Education Platform with Major Cancun Event and Six More In-Country Programs Scheduled LAS VEGAS, NV / ACCESS Newswire / July 24, 2025 / Regenerative Medical Technologies Group, Inc. (OTCID:RMTG), a global leader in regenerative medicine solutions, today announced the successful completion of its ISSCA Argentina 2025 event in Buenos Aires, which attracted hundreds of doctors and medical professionals to the Four Seasons hotel downtown. The Company also announced seven additional ISSCA training events scheduled for 2025, demonstrating continued momentum in its global physician education platform.\r\n Event Success and Revenue Impact:The Buenos Aires event represents RMTG's continued expansion of its ISSCA (International Society for Stem Cell Application) education platform, which generates significant revenue through physician training, certification programs, and product sales. The event featured comprehensive training from theoretical lectures to live clinical practice, with doctors completing certification by working through real-life clinical cases guided by industry experts.\r\n Strategic Training Platform Expansion:\r\n • Proven Demand: Hundreds of physicians filled the Four Seasons hotel, validating market appetite for advanced regenerative medicine training\r\n • Revenue Generation: ISSCA events drive multiple revenue streams including training fees, certification programs, and Cellgenic product sales\r\n • Global Reach: Seven additional events scheduled across key markets including major annual event in Cancun\r\n • Certification Value: Hands-on training with real clinical cases provides premium value proposition for medical professionals\r\n • Product Integration: Cellgenic product line serves as official sponsor, creating direct sales opportunities during training events\r\n We are grateful for the attendance of some of the best doctors who seek out the latest innovations and come to learn new breakthroughs in regenerative med...

More updates from Regenerative Medical Technology Group Inc.